1

ABBV-744 in clinical trials for non-small cell lung cancer (NSCLC) Options

News Discuss 
In Segment A, members will acquire distinct doses and schedules of oral ABBV-744 pill to discover Secure dosing routine. Supplemental participants is going to be enrolled at the recognized monotherapy dosign routine. In Section B, members will get oral ruxolitinib and ABBV-744 will be provided as "insert-on" therapy. In Phase https://michaelt099fqa1.wikinarration.com/user

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story